Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-04-000111
Filing Date
2004-05-12
Accepted
2004-05-12 16:02:19
Documents
1
Period of Report
2004-05-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5947
  Complete submission text file 0001235802-04-000111.txt   7943
Mailing Address C/O HARRIS ASSOCIATES LP TWO NORTH LASALLE STREET CHICAGO IL 60602
Business Address C/O HARRIS ASSOCIATES LP TWO NORTH LASALLE STREET, STE 500 CHICAGO IL 60602-3790
MORGENSTERN VICTOR A (Reporting) CIK: 0000929635 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 04799516

Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)